Specifics of the testing plan have not been developed and will be worked on over the next six to nine months, LPGA commissioner Carolyn Bivens said Wednesday.

``While we have no evidence to date that any of our players are using performance-enhancing drugs, we need to have a very clear policy and a program in place,'' Bivens said. ``We want to take a proactive role.''

The European Tour is working on a policy that chief executive George O'Grady said will be effective ``in the near future.'' The PGA Tour has no drug policy, although its Player Advisory Committee did discuss the issue earlier this year.

Some players, including world No. 1 Tiger Woods, have said there should be drug testing.

Plus, players at last month's world amateur team championships in South Africa were also subject to testing.